MAZ positively regulates CRAF signaling in pancreatic cancer by promoting PAK activation and AKT suppression through phosphorylation at p.S338 and dephosphorylation at p.S259, respectively. The gene discussed is RAF1; the disease is pancreatic neoplasm.